查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1534973

彈性成像市場：現況分析與預測（2024-2032）

Elastography Imaging Market: Current Analysis and Forecast (2024-2032)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

由於企業併購的增加，彈性成像市場預計將以10%左右的速度穩定成長。例如，2024年7月，美國GE醫療同意收購Intelligent Ultrasound Group PLC的臨床人工智慧（AI）軟體業務。 GE HealthCare 計劃將這些解決方案納入其整個超音波產品組合，透過改善工作流程並提高易用性的技術來增強其功能，造福臨床醫生和患者。其他因素，如慢性病的增加、對微創診斷程序的日益偏好以及公司之間的策略聯盟，將在預測期內推動市場成長。除此之外，彈性成像成像的可承受性和可用性的提高也在穩步推動這個市場。

市場依程序分為超音波彈性成像、磁振造影彈性成像等。超音波彈性成像領域因其非侵入性、成本效益以及評估各種醫療狀況的多功能性而在2023年佔據市場主導地位。在該領域，基於超音波的技術用於量化組織硬度，這對於評估肝臟纖維化、乳房組織和肌肉骨骼疾病非常重要。新的發展包括超音波彈性成像解析度的提高和即時分析，這些改進促進了臨床診斷的高精度和廣泛應用。該細分市場的擴張伴隨著對診斷醫療保健、慢性病的流行以及對多樣化且負擔得起的影像解決方案的需求的日益關注。因此，超音波彈性成像可應用於一般診斷和特殊診斷，在現代醫學中具有很高的需求。

依模式劃分，市場分為攜帶式和固定式。預計攜帶式設備將在預測期內顯著成長。攜帶式彈性成像在市場上的需求量很大，因為它用途廣泛、易於使用，並且可以根據患者的要求應用於不同的臨床領域。手持式彈性成像與攜帶式超音波系統整合的優點在於，可以在需要時提供所需的成像和評估，使其適合農村和偏遠地區、急診室和其他護理點環境。這些設備的開發能夠提供出色的影像解析度和硬度測量，同時保持攜帶和易於使用，這要歸功於技術的可用性。由於需要行動醫療服務的人數不斷增加、對快速檢測結果的需求以及醫療服務範圍的擴大，攜帶式細分市場預計將成長。這是由於在靈活的新技術的幫助下，人們不斷轉向提高疾病診斷和治療的可及性和有效性。因此，預計攜帶式細分市場在預測期內將顯著成長。

在市場區隔方面，產品依用途分為心臟病、放射、泌尿、血管、婦產科等。2023年的市場將由心臟病學領域主導。彈性成像市場在心臟病學領域經歷顯著成長，該領域為非侵入性評估和治療心血管疾病提供了創新的解決方案。彈性成像方法逐漸被引進心血管實踐中，以評估心肌硬度和纖維化參數，這對於心臟衰竭、肥厚性心肌病變和心肌梗塞等病理狀況的診斷和監測非常重要。隨著高解析度、即時彈性成像技術的發展和可用性的提高，心臟病的早期診斷已成為可能。該領域的成長是由心血管疾病的日益普及、開發更有效的技術來診斷這些疾病的需求以及從心血管護理到個人化方法的轉變所推動的。彈性成像技術利用測量組織機械特性（例如彈性）的技術，這項發展支持彈性成像技術在增強對患者的心臟護理方面的使用的增加。因此，心臟病學領域在2023年的應用中佔據了重要的市場佔有率。

為了更了解彈性成像的市場導入，市場根據北美（美國、加拿大、北美其他地區）、歐洲（德國、法國、英國、西班牙、義大利、歐洲其他地區）、亞太地區（中國、日本、印度、亞太其他地區）和其他地區的全球影響力進行分析。由於新產品的推出、公司透過併購擴張、對非侵入性診斷的日益偏好、臨床研究的增加以及慢性病發病率的上升，預計北美在預測期內將出現顯著成長。彈性成像成像的可承受性和可用性的提高也推動了該地區的市場成長。因此，在這些地區中，預計北美在預測期內將出現最大的成長。

市場上的主要公司包括 CANON MEDICAL SYSTEMS CORPORATION、Esaote SPA、FUJIFILM Corporation、GE HealthCare、Hologic, Inc.、Koninklijke Philips N.V.、Mindray DS USA, Inc.、Resoundant, Inc.、SAMSUNGHEALTHCARE.COM、Siemens Healthcare Private Limited等。

目錄

第一章 市場介紹

  • 市場定義
  • 主要目的
  • 利害關係人
  • 限制

第二章 研究方法或前提

  • 調查過程
  • 調查方法
  • 受訪者簡介

第3章 執行摘要

  • 行業概況
  • 依細分市場進行預測
    • 市場成長的力量
  • 區域展望

第4章 市場動態

  • 促進因素
  • 機會
  • 抑制因素
  • 趨勢
  • PESTEL 分析
  • 需求方分析
  • 供給面分析
    • 併購
    • 投資場景
    • 產業洞察：主要新創公司及其獨特策略

第五章 價格分析

  • 區域價格分析
  • 影響價格的因素

第6章 2022-2032年全球彈性成像市場營收

第七章 技術市場分析

  • 超音波彈性成像
  • 磁振造影彈性成像
  • 其他

第8章 依模式劃分的市場分析

  • 攜帶式
  • 已修復

第9章 依應用程式進行市場分析

  • 心臟病
  • 輻射
  • 泌尿系統
  • 船隻
  • 婦產科
  • 其他

第10章 依地區劃分的市場分析

  • 北美
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區

第11章 價值鏈分析

  • 邊際分析
  • 進入市場的公司名單

第十二章 競爭態勢

  • 競爭對手儀表板
  • 競爭市場定位分析
  • 波特五力分析

第十三章 公司簡介

  • CANON MEDICAL SYSTEMS CORPORATION
  • Esaote SPA
  • FUJIFILM Corporation
  • GE HealthCare
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Mindray DS USA, Inc.
  • Resoundant, Inc.
  • SAMSUNGHEALTHCARE.COM
  • Siemens Healthcare Private Limited

第14章 首字母縮寫與先決條件

第15章 附錄

簡介目錄
Product Code: UMHE212972

Elastography imaging is a detailed diagnostic modality that is used in measuring tissue's stiffness and elasticity for the purpose of diagnosing as well as managing different disease conditions based on the structural features of tissues. As a mechanical wave-based imaging method, elastography facilitates diagnosing tissue conditions without biopsy, especially for fibrosis, tumors, and musculoskeletal diseases. This technology entails techniques such as transient elastography and shear wave elastography, which are expanding on integration with real-time imaging, and artificial intelligence for improved diagnosing proficiency. Technological advancement in the trend of identifying diseases through non-invasive procedures and adopting patient-specific approaches, including disease diagnosis, has remained instrumental in the construction of elastography imaging across different practices.

The Elastography Imaging Market is expected to grow at a steady rate of around 10% owing to the rising company mergers and acquisitions. For instance, in July 2024, U.S.-based GE HealthCare agreed to acquire Intelligent Ultrasound Group PLC's clinical artificial intelligence (AI) software business. GE Healthcare plans to incorporate these solutions across the ultrasound portfolio, strengthening its capabilities with technology that helps improve workflows and enhance ease of use for the benefit of clinicians and patients. Other factors, including the rising chronic disorders, increasing preference for minimally invasive diagnostic procedures, and strategic partnerships between companies, drive the market's growth during the forecast period. Apart from this, improving the affordability and accessibility of elastography imaging are also driving this market steadily.

Based on the technique, the market is segmented into ultrasound elastography, magnetic resonance elastography, and others. The ultrasound elastography segment dominated the market in the year 2023 driven by its non-invasive nature, cost-effectiveness, and versatility in assessing a wide range of medical conditions. In this segment, the technology used is based on ultrasound for quantification of tissue hardness which is vital in the assessment of liver fibrosis, breast tissues, and disorders of the musculoskeletal system. New developments include improvement in resolution and real-time analysis of ultrasound elastography as these improvements promote high accuracy and broad utilization in clinical diagnosis. The expansion of the segment is supplemented by growing healthcare concerns on diagnostics, the prevalence of chronic diseases, along with the need for diverse affordable imaging solutions. Therefore, ultrasound elastography can be applied for ordinary and specific diagnostic tasks being in high demand in modern medicine.

Based on modality, the market is bifurcated into portable and stationary. The portable segment is expected to grow significantly in the forecast period. The portable type of elastography imaging is experiencing great demand in the market because of its versatility, easy access, and applicability across various areas of clinical practice and patient requirements. Hand-held elastography integrated with portable ultrasound devices has the advantage of point-of-need imaging and assessment which may suit rural and remote areas, emergency departments, and some other point-of-care settings. The development of these devices to provide good image resolution and stiffness measurements while remaining portable and easy to use is due to the availability of technology. The portable segment is expected to grow due to the growing number of people requiring health care services on the go, the need for fast testing results, and the expansion of the scope of medical services. It is attributed to an ongoing shift towards improving the access and effectiveness of diagnosing and treating diseases with the aid of new and flexible technologies. Thus, the portable segment is expected to grow significantly in the forecast period among the modality.

Based on the application, the market is segmented into cardiology, radiology, urology, vascular, obstetrics, and others. The cardiology segment dominated the market in the year 2023. In the elastography imaging market, the cardiology segment has seen significant growth as it offers an innovative solution for evaluating and treating cardiovascular diseases non-invasively. Elastography methods are gradually implemented in sites of cardiological practice in order to assess the parameters of myocardial hardness and fibrosis which are essential for diagnostics as well as the monitoring of pathologies, for example, heart failure, hypertrophic cardiomyopathy, and myocardial infarction. Development and progress in the availability of high-resolution and real-time elastography are enabling better diagnostics of cardiac conditions at an early stage. Segment growth is driven by the increasing incidence of cardiovascular diseases, the need to develop more effective technologies for diagnosing these diseases, and the transition from cardiologic practice to individualized approaches. Elastography leverages technology to determine mechanical properties of the tissue, such as elasticity, and this development underlines the increasing use of elastography in enhancing patients' cardiac care delivery. Thus, the cardiology segment held a significant market share in 2023 among the applications.

For a better understanding of the market adoption of elastography imaging, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is expected to grow at a significant rate in the forecast period due to new product launches, rising company expansions with mergers & acquisitions, rising preference for non-invasive diagnostic procedures, an increasing number of clinical studies, and a rise in chronic disorders. For instance, U.S.-based Emory University initiated a clinical trial to utilize Shear Wave Elastography (SWE) to study the viscoelastic properties of tendons to understand the functional differences between normal/asymptomatic and symptomatic tendon states, which is expected to be completed by 2025. Other factors, such as the improvement in affordability and accessibility of elastography imaging, have pushed the region's market growth. Thus, amongst areas, North America is expected to grow at a significant rate in the forecast period.

Some of the major players operating in the market include CANON MEDICAL SYSTEMS CORPORATION; Esaote SPA; FUJIFILM Corporation; GE HealthCare; Hologic, Inc.; Koninklijke Philips N.V.; Mindray DS USA, Inc.; Resoundant, Inc.; SAMSUNGHEALTHCARE.COM; Siemens Healthcare Private Limited.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Elastography Imaging Market
  • 2.2. Research Methodology of the Elastography Imaging Market
  • 2.3. Respondent Profile

3.EXECUTIVE SUMMARY

  • 3.1. Industry Synopsis
  • 3.2. Segmental Outlook
    • 3.2.1. Market Growth Intensity
  • 3.3. Regional Outlook

4.MARKET DYNAMICS

  • 4.1. Drivers
  • 4.2. Opportunity
  • 4.3. Restraints
  • 4.4. Trends
  • 4.5. PESTEL Analysis
  • 4.6. Demand Side Analysis
  • 4.7. Supply Side Analysis
    • 4.7.1. Merger & Acquisition
    • 4.7.2. Investment Scenario
    • 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

  • 5.1. Regional Pricing Analysis
  • 5.2. Price Influencing Factors

6.GLOBAL ELASTOGRAPHY IMAGING MARKET REVENUE (USD BN), 2022-2032F

7.MARKET INSIGHTS BY TECHNIQUE

  • 7.1. Ultrasound Elastography
  • 7.2. Magnetic Resonance Elastography
  • 7.3. Others

8.MARKET INSIGHTS BY MODALITY

  • 8.1. Portable
  • 8.2. Stationary

9.MARKET INSIGHTS BY APPLICATION

  • 9.1. Cardiology
  • 9.2. Radiology
  • 9.3. Urology
  • 9.4. Vascular
  • 9.5. Obstetrics/Gynecology
  • 9.6. Others

10.MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11.VALUE CHAIN ANALYSIS

  • 11.1. Marginal Analysis
  • 11.2. List of Market Participants

12.COMPETITIVE LANDSCAPE

  • 12.1. Competition Dashboard
  • 12.2. Competitor Market Positioning Analysis
  • 12.3. Porter Five Forces Analysis

13.COMPANY PROFILES

  • 13.1. CANON MEDICAL SYSTEMS CORPORATION
    • 13.1.1. Company Overview
    • 13.1.2. Key Financials
    • 13.1.3. SWOT Analysis
    • 13.1.4. Product Portfolio
    • 13.1.5. Recent Developments
  • 13.2. Esaote SPA
  • 13.3. FUJIFILM Corporation
  • 13.4. GE HealthCare
  • 13.5. Hologic, Inc.
  • 13.6. Koninklijke Philips N.V.
  • 13.7. Mindray DS USA, Inc.
  • 13.8. Resoundant, Inc.
  • 13.9. SAMSUNGHEALTHCARE.COM
  • 13.10. Siemens Healthcare Private Limited

14.ACRONYMS & ASSUMPTION

15.ANNEXURE